ATAC-Seq in LNCaP cell line with GSK treatment and VEH control
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
We show in prostate cancer cells that LSD1 co-localizes with FOXA1 and active enhancer markers, and that LSD1 inhibition globally disrupts FOXA1 chromatin binding. ATAC-Seq analysis was performed in LNCaP cells treated with vehicle or GSK2879552
创建时间：
2020-10-13
